
Isomorphic Labs
Bio AI · Private company
AlphaFold-derived drug design, under Demis Hassabis' dual role.
Company profile
- Valuation
- $600M first external round (2025)
- Backers
- Thrive

Bio AI · Private company
AlphaFold-derived drug design, under Demis Hassabis' dual role.